Login / Signup

Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical Outcomes.

Toshiaki OhkumaMin JunJohn ChalmersMark E CooperPavel HametStephen HarrapSophia ZoungasVlado PerkovicMark Woodwardnull null
Published in: Clinical journal of the American Society of Nephrology : CJASN (2019)
Clinically meaningful decreases in eGFR and increases in UACR over 2 years, independently and in combination, were significantly associated with higher risk of major clinical outcomes.
Keyphrases
  • small cell lung cancer
  • epidermal growth factor receptor
  • tyrosine kinase